Compare BIVI & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIVI | JXG |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2M | 16.9M |
| IPO Year | N/A | N/A |
| Metric | BIVI | JXG |
|---|---|---|
| Price | $1.55 | $4.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 71.9K | ★ 295.6K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.26 |
| Revenue | N/A | ★ $46,835,624.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.88 |
| Revenue Growth | N/A | ★ 21.68 |
| 52 Week Low | $1.25 | $3.01 |
| 52 Week High | $30.90 | $75.37 |
| Indicator | BIVI | JXG |
|---|---|---|
| Relative Strength Index (RSI) | 47.70 | 77.89 |
| Support Level | $1.45 | $3.51 |
| Resistance Level | $1.70 | $4.85 |
| Average True Range (ATR) | 0.10 | 0.53 |
| MACD | 0.04 | 0.23 |
| Stochastic Oscillator | 60.36 | 92.02 |
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.